Business

Ramsay Sante : Provisional annual Results at the end of June 2025

PRESS RELEASE Paris, 27th August 2025 Provisional annual results at the end of June 2025Revenue growth of 4.7% and Group EBITDA up 1.7% despite reduction in public funding; secured long term financing framework Activity growth and cost control mitigate low French tariffs Group revenue increased by 4.7% to €5.2bn supported by activity volume growth and former Cosem primary care centres acquired in June 2024. Revenue growth of 2.7% on a like-for-like basis.Group EBITDA reported for the year ended

articleRamsay Generale De Sante SaAugust 27, 202530/company/ramsay-generale-de-sante-sa/news/ramsay-sante-provisional-annual-results-at-the-end-of-june-2025
Ramsay Sante : Provisional annual Results at the end of June 2025

About this update from Ramsay Generale De Sante Sa

[{"type":"image","alt":"RAMSAY SANTE","displaySize":"","headline":null,"caption":"RAMSAY SANTE","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":288,"url":"https://media.zenfs.com/en/globenewswire.com/959bad3a6a10a6a66985b8a318e1818f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OqHn2cm.eQhr7uXoVH6nZw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQwMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/959bad3a6a10a6a66985b8a318e1818f","width":300,"height":288}},"lazy":false},{"type":"text","content":"PRESS RELEASE","length":13,"tagName":"p"},{"type":"text","content":"Paris, 27th August 2025","length":23,"tagName":"p"},{"type":"text","content":"Provisional annual results at the end of June 2025Revenue growth of 4.7% and Group EBITDA up 1.7% despite reduction in public funding; secured long term financing framework","length":173,"tagName":"p"},{"type":"text","content":"Activity growth and cost control mitigate low French tariffs","length":60,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Group revenue increased by 4.7% to €5.2bn supported by activity volume growth and former Cosem primary care centres acquired in June 2024. Revenue growth of 2.7% on a like-for-like basis.","length":187,"tagName":"p"}]},{"val":[{"type":"text","content":"Group EBITDA reported for the year ended June 2025 was up 1.7% or €10m at €621m, despite the (€53m) decrease in French grants and other funding, as well as industry-wide inflation continuing to be under-funded by governments.","length":225,"tagName":"p"}]},{"val":[{"type":"text","content":"French tariffs experienced a +2,2% increase in French MSO activities from July 2024 from the CICE coefficient cancelation, however not applied in January and February hence with a €9m shortfall, and +0.5% indexation from March 2025. The 2024 prudential coefficient on French tariffed revenue has been withheld entirely by the government, unlike prior years (€15m last year).","length":374,"tagName":"p"}]},{"val":[{"type":"text","content":"French grants curtailed including €21m lower French revenue guarantee, now discontinued, and €17m inflation grant received last year that has not been reconducted.","length":163,"tagName":"p"}]},{"val":[{"type":"text","content":"Cost saving efforts, review of portfolio of facilities and productivity improvements were sustained to absorb reduced gr...

More updates from Ramsay Generale De Sante Sa

FranceRamsay SantéFrancerevenue guaranteeNet cash flowprimary careprimary careRevenue growthCash and cash equivalents